勘误：基于短程放疗与标准长程放化疗的全新辅助治疗用于局部晚期直肠癌：一项随机对照试验的系统评价和荟萃分析
Corrigendum: Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials.
作者信息
Pu Wenji, Chen Wenqi, Jing Haiman, Li Jishi, Jiang Yong, Li Shasha, Wen Weijie, Xu Zhiyuan, Jin Jing
机构信息
Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Medical Department of Shenzhen University, General Hospital of Shenzhen University, Academy of Clinical Medicine of Shenzhen University, Shenzhen, China.
出版信息
Front Oncol. 2025 Jan 14;14:1552188. doi: 10.3389/fonc.2024.1552188. eCollection 2024.
Abstract
[This corrects the article DOI: 10.3389/fonc.2024.1515756.].
摘要
[本文更正了文章DOI：10.3389/fonc.2024.1515756。]
相似文献
1
Corrigendum: Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials.勘误：基于短程放疗与标准长程放化疗的全新辅助治疗用于局部晚期直肠癌：一项随机对照试验的系统评价和荟萃分析
Front Oncol. 2025 Jan 14;14:1552188. doi: 10.3389/fonc.2024.1552188. eCollection 2024.
2
Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.局部进展期直肠癌的新辅助放化疗与总新辅助治疗的比较：贝叶斯网状meta 分析。
Br J Surg. 2023 Jun 12;110(7):784-796. doi: 10.1093/bjs/znad120.
3
A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.一项比较II期和III期直肠癌新辅助治疗策略的随机对照试验的系统评价和网状Meta分析。
Crit Rev Oncol Hematol. 2023 Mar;183:103927. doi: 10.1016/j.critrevonc.2023.103927. Epub 2023 Jan 24.
4
Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials.基于短程放疗与标准长程放化疗的局部晚期直肠癌全新辅助治疗：一项随机对照试验的系统评价和荟萃分析
Front Oncol. 2024 Dec 24;14:1515756. doi: 10.3389/fonc.2024.1515756. eCollection 2024.
5
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.开发和评估一种临床计算器，用于估计接受化疗、放疗和手术治疗的局部晚期直肠癌患者的复发和生存可能性。
JAMA Netw Open. 2021 Nov 1;4(11):e2133457. doi: 10.1001/jamanetworkopen.2021.33457.
6
Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis.局部晚期直肠癌新辅助放化疗时代的治疗选择：系统评价和网络荟萃分析。
JAMA Netw Open. 2024 Jun 3;7(6):e2414702. doi: 10.1001/jamanetworkopen.2024.14702.
7
Evaluating the Impact of Induction and Consolidation Total Neoadjuvant Therapies Compared to Conventional Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.评估诱导和巩固性全新辅助治疗与传统放化疗相比对局部晚期直肠癌的影响：一项系统评价和网状Meta分析
Dis Colon Rectum. 2025 Jun 1;68(6):687-701. doi: 10.1097/DCR.0000000000003687. Epub 2025 Mar 10.
8
Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.局部晚期直肠癌的短程放疗新辅助治疗与长程新辅助放化疗的比较：韩国试验（TV-LARK 试验）：一项多中心随机对照试验的研究方案。
BMC Cancer. 2023 Aug 8;23(1):734. doi: 10.1186/s12885-023-11177-7.
9
Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial.短程放疗联合巩固化疗与常规分割长程放化疗治疗局部进展期直肠癌的随机临床试验。
Br J Surg. 2021 May 27;108(5):511-520. doi: 10.1093/bjs/znab020.
10
Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).韩国结直肠外科学会（KSCP）新辅助同期放化疗后局部中低位进展期直肠癌巩固化疗的临床试验：一项多中心、随机对照试验（KONCLUDE）。
BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7.
Zotero 插件